(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

I INFUGARD

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

I INFUGARD

ST13

US500000079143988

Class

9, 10

Filing

79143988

Registration

4582421

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

52

Latest update

08/02/2024

Trademark type

Combined

Nice classes

9, 10

Filing date

12/17/2013

Registration date

08/12/2014

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/16/2023

Last transaction

11/16/2023

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

3

Owner type

16

Owner location

Vilnius, LT

Examiner

HUSSAIN, TASNEEM

Law office

M90

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of the wording "INFUGARD" with "INFU" in red and "GARD" in black; above the wording is a shield outlined in black and a partial grey border within which is a white background featuring a red letter "I"; the background is white.

Holders and representatives

Holders

Uzdaroji akcine bendrove "VILTECHMEDA"
Uzdaroji akcine bendrove "VILTECHMEDA"

Representatives

Nicholas D. Wells Legends Law Group, PLLC

Technical classification

Nice Classes

Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Computer software that enables hospitals to customize dosage limits and accurately monitor drug delivery to prevent medication errors and for control of medical devices; computer application software that enables hospitals to customize dosage limits and accurately monitor drug delivery to prevent medication errors and for control of medical devices; recorded computer programs that enable hospitals to customize dosage limits and accurately monitor drug delivery to prevent medication errors and for control of medical devices; downloadable computer programs that enable hospitals to customize dosage limits and accurately monitor drug delivery to prevent medication errors and for control of medical devices; software for controlling and monitoring of infusion processes

Class 10

Medical apparatus and instrumentsinfusion setsinfusion pumps for delivering measured amounts of solutions into the bloodstream over time; injection devices for pharmaceuticals; infusion pumps for delivering medication; intravenous infusion pumps for medical purposes; medical infusion pumps

Publications

History of USPTO decisions and trademark events.

52 publications found

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

08/02/2024

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

07/17/2024

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

11/16/2023

71AG

REGISTERED-SEC.71 ACCEPTED

11/16/2023

RNWL

INTERNATIONAL REGISTRATION RENEWED

10/20/2023

ES71

TEAS SECTION 71 RECEIVED

10/18/2023

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

08/12/2023

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

08/24/2022

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

07/19/2022

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

05/23/2022

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

04/05/2022

XXCR

GENERIC MADRID TRANSACTION CREATED

04/05/2022

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

11/19/2021

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

11/19/2021

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

11/17/2021

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

08/18/2021

PR71

POST REGISTRATION ACTION MAILED - SEC.71

03/17/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/04/2021

ES71

TEAS SECTION 71 RECEIVED

02/05/2021

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

10/09/2019

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

08/12/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/17/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/08/2016

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/19/2015

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/30/2015

FIMP

FINAL DISPOSITION PROCESSED

01/30/2015

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/12/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

08/12/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/27/2014

PUBO

PUBLISHED FOR OPPOSITION

05/27/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/07/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/19/2014

RFNT

REFUSAL PROCESSED BY IB

04/18/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/14/2014

XAEC

EXAMINER'S AMENDMENT ENTERED

04/11/2014

ALIE

ASSIGNED TO LIE

04/11/2014

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/11/2014

GNEA

EXAMINERS AMENDMENT E-MAILED

04/11/2014

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/11/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/10/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/09/2014

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/09/2014

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/09/2014

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/09/2014

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/03/2014

RFRR

REFUSAL PROCESSED BY MPU

04/03/2014

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/02/2014

CNRT

NON-FINAL ACTION WRITTEN

04/01/2014

DOCK

ASSIGNED TO EXAMINER

03/25/2014

MAFR

APPLICATION FILING RECEIPT MAILED

03/25/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/21/2014

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/20/2014

Continuous trademark protection

Get notified about every new filing that threatens I INFUGARD or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.